Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium Tuberculosis in China
Overview
Authors
Affiliations
Background: The increase in multidrug-resistant tuberculosis (MDR-TB) severely hampers tuberculosis prevention and control in China, a country with the second highest MDR-TB burden globally. The first nationwide drug-resistant tuberculosis surveillance program provides an opportunity to comprehensively investigate the epidemiological/drug-resistance characteristics, potential drug-resistance mutations, and effective population changes of Chinese MDR-TB.
Methods: We sequenced 357 MDR strains from 4600 representative tuberculosis-positive sputum samples collected during the survey (70 counties in 31 provinces). Drug-susceptibility testing was performed using 18 anti-tuberculosis drugs, representing the most comprehensive drug-resistance profile to date. We used 3 statistical and 1 machine-learning methods to identify drug-resistance genes/single-nucleotide polymorphisms (SNPs). We used Bayesian skyline analysis to investigate changes in effective population size.
Results: Epidemiological/drug-resistance characteristics showed different MDR profiles, co-resistance patterns, preferred drug combination/use, and recommended regimens among 7 Chinese administrative regions. These factors not only reflected the serious multidrug co-resistance and drug misuse but they were also potentially significant in facilitating the development of appropriate regimens for MDR-TB treatment in China. Further investigation identified 86 drug-resistance genes/intergenic regions/SNPs (58 new), providing potential targets for MDR-TB diagnosis and treatment. In addition, the effective population of Chinese MDR-TB displayed a strong expansion during 1993-2000, reflecting socioeconomic transition within the country. The phenomenon of expansion was restrained after 2000, likely attributable to the advances in diagnosis/treatment technologies and government support.
Conclusions: Our findings provide an important reference and improved understanding of MDR-TB in China, which are potentially significant in achieving the goal of precision medicine with respect to MDR-TB prevention and treatment.
Association between toxin-antitoxin system mutations and global transmission of MDR-TB.
Li Y, Shao Y, Li Y, Kong X, Tao N, Hou Y BMC Infect Dis. 2024; 24(1):1250.
PMID: 39501228 PMC: 11539496. DOI: 10.1186/s12879-024-10142-4.
A Profile of Drug-Resistant Mutations in Isolates from Guangdong Province, China.
Zhang C, Wu Z, Huang X, Zhao Y, Sun Q, Chen Y Indian J Microbiol. 2024; 64(3):1044-1056.
PMID: 39282200 PMC: 11399372. DOI: 10.1007/s12088-024-01236-3.
Li Y, Li Y, Liu Y, Kong X, Tao N, Hou Y BMC Genomics. 2024; 25(1):810.
PMID: 39198760 PMC: 11350932. DOI: 10.1186/s12864-024-10726-z.
Toxin-antitoxin system gene mutations driving transmission revealed by whole genome sequencing.
Hou Y, Li Y, Tao N, Kong X, Li Y, Liu Y Front Microbiol. 2024; 15:1398886.
PMID: 39144214 PMC: 11322068. DOI: 10.3389/fmicb.2024.1398886.
Dixit A, Ektefaie Y, Kagal A, Freschi L, Karyakarte R, Lokhande R J Infect Dis. 2024; 231(1):84-93.
PMID: 38819323 PMC: 11793027. DOI: 10.1093/infdis/jiae240.